As Brexit row become increasingly anarchic, is UK’s reputation with pharma suffering?

The political crisis surrounding Brexit shows little sign of ending after the tumultuous events of this week. Paul Ranson and Jeffry Mann from Morgan Lewis’ life sciences group, spoke to pharmaphorum’s Richard Staines to give their perspectives on how the uncertainty is affecting life sciences companies, and whether the increasingly embarrassing political row is undermining industry’s trust in the UK.